While the radioactive conjugate, [18F]F-TZ(PSMA)-LEGU-TLR7), is intended for positron emission tomography (PET) imaging, its cold counterpart, [19F]F-TZ(PSMA)-LEGU-TLR7, can be formulated for cancer immunomodulatory therapy. The gene discussed is TLR7; the disease is cancer.